Rating History for Merrimack Pharmaceuticals (MACK) by Brean Capital

More Stocks Rated by Brean Capital | Latest Ratings for MACK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/27/2012 N/A New Coverage Buy
(N/A)		 12.00
(N/A)		 9.17
(15.13)		 64.99% Details